• OPEN AN ACCOUNT
Indian Indices
Nifty
24,750.70 -82.90
(-0.33%)
Sensex
81,451.01 -182.01
( -0.22%)
Bank Nifty
55,749.70 203.65
( 0.37%)
Nifty IT
37,321.75 -432.40
( -1.15%)
Global Indices
Nasdaq
42,280.67 43.94
(0.10%)
Dow Jones
5,931.28 -1.89
(-0.03%)
Hang Seng
38,097.61 -335.37
(-0.87%)
Nikkei 225
8,772.38 55.93
(0.64%)
Forex
USD-INR
85.50 0.07
(0.09%)
EUR-INR
97.01 0.42
(0.44%)
GBP-INR
115.18 0.03
(0.03%)
JPY-INR
0.59 0.00
(0.53%)

EQUITY - MARKET SCREENER

IBL Finance Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
91871
INE0O7401018
23.7198173
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
IBLFL
64.79
152.22
EPS(TTM)
Face Value()
Div & Yield %
0.95
10
0
 

Dr Reddy's Laboratories consolidated net profit rises 21.64% in the March 2025 quarter
May 09,2025
Net profit of Dr Reddy's Laboratories rose 21.64% to Rs 1593.30 crore in the quarter ended March 2025 as against Rs 1309.80 crore during the previous quarter ended March 2024. Sales rose 20.09% to Rs 8506.00 crore in the quarter ended March 2025 as against Rs 7083.00 crore during the previous quarter ended March 2024.

For the full year,net profit rose 1.38% to Rs 5655.10 crore in the year ended March 2025 as against Rs 5577.90 crore during the previous year ended March 2024. Sales rose 16.61% to Rs 32553.50 crore in the year ended March 2025 as against Rs 27916.40 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales8506.007083.00 20 32553.5027916.40 17
OPM %23.4925.85 -26.2628.42 -
PBDT2459.901972.90 25 9383.208671.00 8
PBT2005.201605.20 25 7679.507201.00 7
NP1593.301309.80 22 5655.105577.90 1